Insys Therapeutics (INSY) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Insys Therapeutics (INSY) Tops Q1 EPS by 4c

Insys Therapeutics Reports First Quarter 2016 Results

April 28, 2016 6:50 AM EDT

PHOENIX, April 28, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced financial results for the three-month period ended March 31, 2016.

Highlights of and subsequent to the first quarter of 2016 include:

Total net revenue decreased to $62.0 million, compared to $70.8 million for the first quarter of 2015;Revenue from Subsys® (fentanyl sublingual spray) was $62.0, down 12% compared with first quarter 2015 revenue of $70.5 million;Net income was $2.4 million, or $0.03 per basic and $0.03 per diluted share, compared to net income of $8.0 million, or $0.11 per basic and $0.11 per diluted share,... More